LALPATHLAB.NS Balance Sheet
Dr. Lal Path Labs Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:45
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹4.01 Bn | ₹3.43 Bn | ₹3.36 Bn | ₹4.84 Bn | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹0.03 Bn | ₹0.04 Bn | ₹0.04 Bn | ₹0.06 Bn | CapitalWorkInProgress |
| Goodwill | ₹5.48 Bn | ₹5.48 Bn | ₹5.48 Bn | ₹5.48 Bn | Goodwill |
| Other Intangible Assets | ₹3.56 Bn | ₹3.03 Bn | ₹2.51 Bn | ₹1.92 Bn | OtherIntangibleAssets |
| Non-current Investments | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | NoncurrentInvestments |
| Other Non-current Assets | ₹0.22 Bn | ₹0.20 Bn | ₹0.14 Bn | ₹0.20 Bn | OtherNoncurrentAssets |
| Total Non-current Assets | ₹14.12 Bn | ₹13.29 Bn | ₹13.53 Bn | ₹15.79 Bn | NoncurrentAssets |
| Inventories | ₹0.34 Bn | ₹0.37 Bn | ₹0.36 Bn | ₹0.44 Bn | Inventories |
| Trade Receivables | ₹0.71 Bn | ₹0.77 Bn | ₹0.88 Bn | ₹1.11 Bn | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹2.64 Bn | ₹3.61 Bn | ₹2.93 Bn | ₹2.43 Bn | CashAndCashEquivalents |
| Current Investments | ₹1.50 Bn | ₹1.14 Bn | ₹3.27 Bn | ₹4.23 Bn | CurrentInvestments |
| Other Current Assets | ₹0.16 Bn | ₹0.20 Bn | ₹0.22 Bn | ₹0.22 Bn | OtherCurrentAssets |
| Total Current Assets | ₹9.73 Bn | ₹11.27 Bn | ₹13.63 Bn | ₹15.67 Bn | CurrentAssets |
| Total Assets | ₹23.86 Bn | ₹24.56 Bn | ₹27.17 Bn | ₹31.46 Bn | Assets |
| Equity Share Capital | ₹0.83 Bn | ₹0.83 Bn | ₹0.84 Bn | ₹1.68 Bn | EquityShareCapital |
| Other Equity | ₹15.83 Bn | ₹17.66 Bn | ₹20.89 Bn | ₹23.41 Bn | OtherEquity |
| Equity Attributable to Owners | ₹16.66 Bn | ₹18.49 Bn | ₹21.73 Bn | ₹25.08 Bn | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹0.33 Bn | ₹0.36 Bn | ₹0.34 Bn | ₹0.33 Bn | NonControllingInterest |
| Total Equity | ₹17.00 Bn | ₹18.85 Bn | ₹22.07 Bn | ₹25.41 Bn | Equity |
| Long-term Borrowings | ₹0.83 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹2.16 Bn | ₹1.05 Bn | ₹1.08 Bn | ₹1.54 Bn | NoncurrentLiabilities |
| Short-term Borrowings | ₹1.53 Bn | ₹0.83 Bn | ₹0.00 Bn | ₹0.00 Bn | BorrowingsCurrent |
| Trade Payables | ₹1.56 Bn | ₹1.87 Bn | ₹1.99 Bn | ₹1.81 Bn | TradePayablesCurrent |
| Other Current Liabilities | ₹0.32 Bn | ₹0.35 Bn | ₹0.43 Bn | ₹0.42 Bn | OtherCurrentLiabilities |
| Total Current Liabilities | ₹4.70 Bn | ₹4.65 Bn | ₹4.03 Bn | ₹4.51 Bn | CurrentLiabilities |
| Total Equity and Liabilities | ₹23.86 Bn | ₹24.56 Bn | ₹27.17 Bn | ₹31.46 Bn | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from LALPATHLAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).